Toward Rigorous Materials Production: New Approach Methodologies Have Extensive Potential to Improve Current Safety Assessment Practices.

Advanced material development, including at the nanoscale, comprises costly and complex challenges coupled to ensuring human and environmental safety. Governmental agencies regulating safety have announced interest toward acceptance of safety data generated under the collective term New Approach Methodologies (NAMs), as such technologies/approaches offer marked potential to progress the integration of safety testing measures during innovation from idea to product launch of nanomaterials. Divided in overall eight main categories, searchable databases for grouping and read across purposes, exposure assessment and modeling, in silico modeling of physicochemical structure and hazard data, in vitro high-throughput and high-content screening assays, dose-response assessments and modeling, analyses of biological processes and toxicity pathways, kinetics and dose extrapolation, consideration of relevant exposure levels and biomarker endpoints typify such useful NAMs. Their application generally agrees with articulated stakeholder needs for improvement of safety testing procedures. They further fit for inclusion and add value in nanomaterials risk assessment tools. Overall 37 of 50 evaluated NAMs and tiered workflows applying NAMs are recommended for considering safer-by-design innovation, including guidance to the selection of specific NAMs in the eight categories. An innovation funnel enriched with safety methods is ultimately proposed under the central aim of promoting rigorous nanomaterials innovation.

[1]  Pekka Kohonen,et al.  Toxic and Genomic Influences of Inhaled Nanomaterials as a Basis for Predicting Adverse Outcome. , 2018, Annals of the American Thoracic Society.

[2]  B. Thomsen,et al.  A Proposed In Vitro Method to Assess Effects of Inhaled Particles on Lung Surfactant Function. , 2016, American journal of respiratory cell and molecular biology.

[3]  Alexander Golbraikh,et al.  Integrative chemical-biological read-across approach for chemical hazard classification. , 2013, Chemical research in toxicology.

[4]  Georgia Tsiliki,et al.  A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  Timothy F. Malloy,et al.  Policy reforms to update chemical safety testing , 2017, Science.

[6]  Enrico Burello,et al.  Proposal for a risk banding framework for inhaled low aspect ratio nanoparticles based on physicochemical properties , 2016, Nanotoxicology.

[7]  José María Navas,et al.  Quality evaluation of human and environmental toxicity studies performed with nanomaterials – the GUIDEnano approach , 2018 .

[8]  Ola Spjuth,et al.  Cancer biology, toxicology and alternative methods development go hand-in-hand. , 2014, Basic & clinical pharmacology & toxicology.

[9]  David Brown,et al.  Organ burden and pulmonary toxicity of nano-sized copper (II) oxide particles after short-term inhalation exposure , 2016, Nanotoxicology.

[10]  Flemming R. Cassee,et al.  On the pivotal role of dose for particle toxicology and risk assessment: exposure is a poor surrogate for delivered dose , 2017, Particle and Fibre Toxicology.

[11]  Robert J Kavlock,et al.  Accelerating the Pace of Chemical Risk Assessment. , 2018, Chemical research in toxicology.

[12]  Mary Gulumian,et al.  Label-free in vitro toxicity and uptake assessment of citrate stabilised gold nanoparticles in three cell lines , 2013, Particle and Fibre Toxicology.

[13]  Fred A. Wright,et al.  A chemical–biological similarity-based grouping of complex substances as a prototype approach for evaluating chemical alternatives† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c6gc01147k Click here for additional data file. , 2016, Green chemistry : an international journal and green chemistry resource : GC.

[14]  Skylar W. Marvel,et al.  ToxPi Graphical User Interface 2.0: Dynamic exploration, visualization, and sharing of integrated data models , 2018, BMC Bioinformatics.

[15]  Andrea Haase,et al.  Nanomaterial grouping: Existing approaches and future recommendations , 2019, NanoImpact.

[16]  Jiri Aubrecht,et al.  Validation of Transcriptomics-Based In Vitro Methods. , 2016, Advances in experimental medicine and biology.

[17]  Wout Slob,et al.  Shape and steepness of toxicological dose–response relationships of continuous endpoints , 2014, Critical reviews in toxicology.

[18]  Rong Liu,et al.  Implementation of a multidisciplinary approach to solve complex nano EHS problems by the UC Center for the Environmental Implications of Nanotechnology. , 2013, Small.

[19]  Kan Shao,et al.  Is the assumption of normality or log-normality for continuous response data critical for benchmark dose estimation? , 2013, Toxicology and applied pharmacology.

[20]  Sharon Munn,et al.  The Adverse Outcome Pathway approach in nanotoxicology , 2017 .

[21]  Andrew Worth,et al.  Ab initio chemical safety assessment: A workflow based on exposure considerations and non-animal methods , 2017, Computational toxicology.

[22]  J. Dearden,et al.  QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.

[23]  Martin Fritts,et al.  Integration among databases and data sets to support productive nanotechnology: Challenges and recommendations , 2018, NanoImpact.

[24]  Thomas Hartung,et al.  Big-data and machine learning to revamp computational toxicology and its use in risk assessment. , 2018, Toxicology research.

[25]  Bruce C Allen,et al.  Benchmark dose (BMD) modeling: current practice, issues, and challenges , 2018, Critical reviews in toxicology.

[26]  Andrew Williams,et al.  Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials , 2015, Particle and Fibre Toxicology.

[27]  Christian Micheletti,et al.  Implementation of Safe-by-Design for Nanomaterial Development and Safe Innovation: Why We Need a Comprehensive Approach , 2018, Nanomaterials.

[28]  Miikka Dal Maso,et al.  Comparison of Geometrical Layouts for a Multi-Box Aerosol Model from a Single-Chamber Dispersion Study , 2018 .

[29]  M. Vetten,et al.  From the Cover: An Investigation of the Genotoxicity and Interference of Gold Nanoparticles in Commonly Used In Vitro Mutagenicity and Genotoxicity Assays , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  Valérie Zuang,et al.  A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.

[31]  Andrew Worth,et al.  Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA). , 2014, Regulatory toxicology and pharmacology : RTP.

[32]  Schuur Ag,et al.  ConsExpo Web : Consumer exposure models - Model documentation , 2016 .

[33]  Thomas Hartung,et al.  21st Century Cell Culture for 21st Century Toxicology. , 2017, Chemical research in toxicology.

[34]  Ivan Rusyn,et al.  The Impact of Novel Assessment Methodologies in Toxicology on Green Chemistry and Chemical Alternatives , 2018, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  Hans Marquart,et al.  RISKOFDERM: risk assessment of occupational dermal exposure to chemicals. An introduction to a series of papers on the development of a toolkit. , 2003, The Annals of occupational hygiene.

[36]  Bruce C Allen,et al.  BMDExpress: a software tool for the benchmark dose analyses of genomic data , 2007, BMC Genomics.

[37]  Sijie Lin,et al.  Nanomaterials Safer‐by‐Design: An Environmental Safety Perspective , 2018, Advances in Materials.

[38]  Margriet Vdz Park,et al.  Development of a systematic method to assess similarity between nanomaterials for human hazard evaluation purposes – lessons learnt , 2018, Nanotoxicology.

[39]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[40]  Detlef Ritter,et al.  Air–Liquid Interface In Vitro Models for Respiratory Toxicology Research: Consensus Workshop and Recommendations , 2018, Applied in vitro toxicology.

[41]  Saji George,et al.  A predictive toxicological paradigm for the safety assessment of nanomaterials. , 2009, ACS nano.

[42]  Antonio Marcomini,et al.  Frameworks and tools for risk assessment of manufactured nanomaterials. , 2016, Environment international.

[43]  Roberto Tagliaferri,et al.  INSIdE NANO: a systems biology framework to contextualize the mechanism-of-action of engineered nanomaterials , 2019, Scientific Reports.

[44]  Vittorio Fortino,et al.  INfORM: Inference of NetwOrk Response Modules , 2018, Bioinform..

[45]  Egon L. Willighagen,et al.  Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials , 2018, Front. Genet..

[46]  Kari E. J. Lehtinen,et al.  Multicomponent aerosol dynamics model UHMA: model development and validation , 2004 .

[47]  Ola Spjuth,et al.  Toward the Replacement of Animal Experiments through the Bioinformatics-driven Analysis of ‘Omics’ Data from Human Cell Cultures , 2015, Alternatives to laboratory animals : ATLA.

[48]  S. Kežić,et al.  Progress and future of in vitro models to study translocation of nanoparticles , 2015, Archives of Toxicology.

[49]  Egon L. Willighagen,et al.  RRegrs: an R package for computer-aided model selection with multiple regression models , 2015, Journal of Cheminformatics.

[50]  Melvin E. Andersen,et al.  Developing tools for defining and establishing pathways of toxicity , 2015, Archives of Toxicology.

[51]  M Levin,et al.  Testing the near field/far field model performance for prediction of particulate matter emissions in a paint factory. , 2015, Environmental science. Processes & impacts.

[52]  Min Li,et al.  Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles , 2016, The AAPS Journal.

[53]  Georgia Tsiliki,et al.  toxFlow: A Web-Based Application for Read-Across Toxicity Prediction Using Omics and Physicochemical Data , 2017, J. Chem. Inf. Model..

[54]  Aron Walsh,et al.  The 2019 materials by design roadmap , 2018, Journal of physics D: Applied physics.

[55]  Haralambos Sarimveis,et al.  Transcriptomics in Toxicogenomics, Part III: Data Modelling for Risk Assessment , 2020, Nanomaterials.

[56]  Jeremy M. Gernand,et al.  Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials , 2016, Risk analysis : an official publication of the Society for Risk Analysis.

[57]  Y. Zuo,et al.  Biophysical influence of airborne carbon nanomaterials on natural pulmonary surfactant. , 2015, ACS nano.

[58]  Agnieszka Gajewicz,et al.  What if the number of nanotoxicity data is too small for developing predictive Nano-QSAR models? An alternative read-across based approach for filling data gaps. , 2017, Nanoscale.

[59]  Lang Tran,et al.  Adoption of in vitro systems and zebrafish embryos as alternative models for reducing rodent use in assessments of immunological and oxidative stress responses to nanomaterials , 2018, Critical reviews in toxicology.

[60]  Andrew Williams,et al.  Ranking of nanomaterial potency to induce pathway perturbations associated with lung responses , 2019, NanoImpact.

[61]  Miikka Dal Maso,et al.  Source specific exposure and risk assessment for indoor aerosols. , 2019, The Science of the total environment.

[62]  John J. Schlager,et al.  Toxicity Evaluation for Safe Use of Nanomaterials: Recent Achievements and Technical Challenges , 2009 .

[63]  Dominique Lison,et al.  Mechanisms of lung fibrosis induced by carbon nanotubes: towards an Adverse Outcome Pathway (AOP) , 2015, Particle and Fibre Toxicology.

[64]  A. Luch,et al.  Comparative modeling of exposure to airborne nanoparticles released by consumer spray products , 2016, Nanotoxicology.

[65]  Andrey A Toropov,et al.  Nano-QSAR in cell biology: Model of cell viability as a mathematical function of available eclectic data. , 2017, Journal of theoretical biology.

[66]  Philip Demokritou,et al.  An integrated approach for the in vitro dosimetry of engineered nanomaterials , 2014, Particle and Fibre Toxicology.

[67]  Raffaella Corvi,et al.  3S – Systematic, Systemic, and Systems Biology and Toxicology , 2019, ALTEX.

[68]  Wouter Fransman,et al.  LICARA nanoSCAN - A tool for the self-assessment of benefits and risks of nanoproducts. , 2016, Environment international.

[69]  Nicklas Raun Jacobsen,et al.  Comparative Hazard Identification by a Single Dose Lung Exposure of Zinc Oxide and Silver Nanomaterials in Mice , 2015, PloS one.

[70]  Helene Stockmann-Juvala,et al.  A theoretical approach for a weighted assessment of the mutagenic potential of nanomaterials , 2017, Nanotoxicology.

[71]  Lang Tran,et al.  ITS-NANO - Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy , 2014, Particle and Fibre Toxicology.

[72]  Scott C. Wesselkamper,et al.  Editor's Highlight: Application of Gene Set Enrichment Analysis for Identification of Chemically Induced, Biologically Relevant Transcriptomic Networks and Potential Utilization in Human Health Risk Assessment , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[73]  D. Dix,et al.  Informing Selection of Nanomaterial Concentrations for ToxCast in Vitro Testing Based on Occupational Exposure Potential , 2011, Environmental health perspectives.

[74]  Carole L Yauk,et al.  Promise and peril in nanomedicine: the challenges and needs for integrated systems biology approaches to define health risk , 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[75]  G. Kaptay,et al.  On the size and shape dependence of the solubility of nano-particles in solutions. , 2012, International journal of pharmaceutics.

[76]  D BurgoonLyle,et al.  The AOPOntology: A Semantic Artificial Intelligence Tool for Predictive Toxicology , 2017 .

[77]  S. H. Bennekou,et al.  Adverse outcome pathways: opportunities, limitations and open questions , 2017, Archives of Toxicology.

[78]  Igor Linkov,et al.  Sustainable nanotechnology decision support system: bridging risk management, sustainable innovation and risk governance , 2016, Journal of Nanoparticle Research.

[79]  Brian L. Murphy,et al.  Modeling Indoor Air Exposure from Short‐Term Point Source Releases , 1996 .

[80]  Philip Demokritou,et al.  Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials , 2017, Nature Protocols.

[81]  Steffen Foss Hansen,et al.  Control banding tools for occupational exposure assessment of nanomaterials — Ready for use in a regulatory context? , 2016 .

[82]  Joris T.K. Quik,et al.  Directions in QPPR development to complement the predictive models used in risk assessment of nanomaterials , 2018, NanoImpact.

[83]  Haralambos Sarimveis,et al.  Perspectives from the NanoSafety Modelling Cluster on the validation criteria for (Q)SAR models used in nanotechnology. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[84]  Kee Woei Ng,et al.  Emerging in vitro models for safety screening of high-volume production nanomaterials under environmentally relevant exposure conditions. , 2013, Small.

[85]  R Damoiseaux,et al.  No time to lose--high throughput screening to assess nanomaterial safety. , 2011, Nanoscale.

[86]  Peter Wick,et al.  Nanoparticle transport across the placental barrier: pushing the field forward! , 2016, Nanomedicine.

[87]  Stephen W. Edwards,et al.  Systems Biology and Biomarkers of Early Effects for Occupational Exposure Limit Setting , 2015, Journal of occupational and environmental hygiene.

[88]  Robert G. Cooper,et al.  Stage-gate systems: A new tool for managing new products , 1990 .

[89]  Bryant C Nelson,et al.  Emerging metrology for high-throughput nanomaterial genotoxicology. , 2017, Mutagenesis.

[90]  Egon L. Willighagen,et al.  eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment , 2015, Journal of Biomedical Semantics.

[91]  David M. Reif,et al.  Incorporating exposure information into the toxicological prioritization index decision support framework. , 2012, The Science of the total environment.

[92]  Xiang Wang,et al.  Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. , 2013, Accounts of chemical research.

[93]  C. Austin,et al.  Improving the Human Hazard Characterization of Chemicals: A Tox21 Update , 2013, Environmental health perspectives.

[94]  Robert G. Cooper,et al.  What's Next?: After Stage-Gate , 2014 .

[95]  K. Dawson,et al.  Microscopy-based high-throughput assays enable multi-parametric analysis to assess adverse effects of nanomaterials in various cell lines , 2017, Archives of Toxicology.

[96]  K. Hougaard,et al.  Prediction of acute inhalation toxicity using in vitro lung surfactant inhibition. , 2018, ALTEX.

[97]  Blanca Suarez-Merino,et al.  High throughput toxicity screening and intracellular detection of nanomaterials , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[98]  E. J. Foster,et al.  An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles , 2014, Particle and Fibre Toxicology.

[99]  Lauren Heine,et al.  Advancing alternatives analysis: The role of predictive toxicology in selecting safer chemical products and processes. , 2017, Integrated environmental assessment and management.

[100]  Robert Landsiedel,et al.  Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making. , 2015, ACS nano.

[101]  Kirk G Scheckel,et al.  A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials , 2017, Critical reviews in toxicology.

[102]  Andrew Williams,et al.  Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes , 2015, Particle and Fibre Toxicology.

[103]  Terry W Schultz,et al.  The Adverse Outcome Pathway for Skin Sensitisation: Moving Closer to Replacing Animal Testing , 2016, Alternatives to laboratory animals : ATLA.

[104]  Joel G Pounds,et al.  ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.

[105]  Helinor Johnston,et al.  Development of in vitro systems for nanotoxicology: methodological considerations , 2009, Critical reviews in toxicology.

[106]  Alexandra Maertens,et al.  Integrated testing strategies for safety assessments. , 2013, ALTEX.

[107]  Erik Tielemans,et al.  Classification of occupational activities for assessment of inhalation exposure. , 2011, The Annals of occupational hygiene.

[108]  Georgia Tsiliki,et al.  The eNanoMapper database for nanomaterial safety information , 2015, Beilstein journal of nanotechnology.

[109]  Pantelis Sopasakis,et al.  Jaqpot Quattro: A Novel Computational Web Platform for Modeling and Analysis in Nanoinformatics , 2017, J. Chem. Inf. Model..

[110]  Andrew Williams,et al.  Application of biclustering of gene expression data and gene set enrichment analysis methods to identify potentially disease causing nanomaterials , 2015, Beilstein journal of nanotechnology.

[111]  Fred A. Wright,et al.  ToxPi GUI: an interactive visualization tool for transparent integration of data from diverse sources of evidence , 2013, Bioinform..

[112]  Mark D. Hoover,et al.  The Nanomaterial Data Curation Initiative: A collaborative approach to assessing, evaluating, and advancing the state of the field , 2015, Beilstein journal of nanotechnology.

[113]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[114]  Christian Micheletti,et al.  Safe innovation approach: Towards an agile system for dealing with innovations , 2019, Materials Today Communications.

[115]  M. Andersen,et al.  Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment. , 2015, Toxicology.

[116]  Jelena Srebric,et al.  Advanced computational modeling for in vitro nanomaterial dosimetry , 2015, Particle and Fibre Toxicology.

[117]  Qasim Chaudhry,et al.  Aligning nanotoxicology with the 3Rs: What is needed to realise the short, medium and long-term opportunities? , 2017, Regulatory toxicology and pharmacology : RTP.

[118]  Liang Yan,et al.  A Safe‐by‐Design Strategy towards Safer Nanomaterials in Nanomedicines , 2019, Advanced materials.

[119]  Sijin Liu,et al.  Mesoporous carbon nanomaterials induced pulmonary surfactant inhibition, cytotoxicity, inflammation and lung fibrosis. , 2017, Journal of environmental sciences.

[120]  Krister Wennerberg,et al.  A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury , 2017, Nature Communications.

[121]  Susan Wijnhoven,et al.  Risk assessment frameworks for nanomaterials: Scope, link to regulations, applicability, and outline for future directions in view of needed increase in efficiency , 2018 .

[122]  Georgia Tsiliki,et al.  Enriching Nanomaterials Omics Data: An Integration Technique to Generate Biological Descriptors , 2017 .

[123]  Jerzy Leszczynski,et al.  NanoSolveIT Project: Driving nanoinformatics research to develop innovative and integrated tools for in silico nanosafety assessment , 2020, Computational and structural biotechnology journal.

[124]  Thomas Hartung,et al.  Green toxicology. , 2014, ALTEX.

[125]  Katarzyna Odziomek,et al.  Decision tree models to classify nanomaterials according to the DF4nanoGrouping scheme , 2018, Nanotoxicology.

[126]  Stephen W. Edwards,et al.  The Adverse Outcome Pathway: A Multifaceted Framework Supporting 21st Century Toxicology. , 2018, Current opinion in toxicology.

[127]  Lisa M. Sweeney,et al.  Advances in Inhalation Dosimetry Models and Methods for Occupational Risk Assessment and Exposure Limit Derivation , 2015, Journal of occupational and environmental hygiene.

[128]  Mikko Poikkimäki,et al.  Ranking of human risk assessment models for manufactured nanomaterials along the Cooper stage-gate innovation funnel using stakeholder criteria , 2020 .

[129]  V. Rogiers,et al.  Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective , 2015, Archives of Toxicology.

[130]  Thomas Hartung,et al.  Perspectives on validation of high-throughput assays supporting 21st century toxicity testing. , 2013, ALTEX.

[131]  Ruud Boessen,et al.  Evaluation of Decision Rules in a Tiered Assessment of Inhalation Exposure to Nanomaterials. , 2016, The Annals of occupational hygiene.